Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04268498 |
Title | A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma |
Acronym | ADVANCE |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Memorial Sloan Kettering Cancer Center |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of Miami | Miami | Florida | 33136 | United States | Details | |
Moffitt Cancer Center | Tampa | Florida | 33612-9497 | United States | Details | |
Roswell Park Comprehensive Cancer Center | Buffalo | New York | 14203 | United States | Details | |
Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | United States | Details | |
Stony Brook University | Stony Brook | New York | 11794 | United States | Details | |
MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
Huntsman Cancer Institue | Salt Lake City | Utah | 84113 | United States | Details |